Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jaidev Sudagani"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 8, Pp BC19-BC23 (2016)
Introduction: There were 72 million adults with Diabetes Mellitus (DM) in 2013 in the South East Asian region of which India is a part. This figure is expected to rise to more than 123 million by 2035. Some studies have also shown that there is an
Externí odkaz:
https://doaj.org/article/58776247abce40929ae0fab03a830634
Autor:
Nikhil Bangale, M. Mahesh, Jaidev Sudagani, S Sridhar Mylapore, B. B. Bharti, Vinay Kumar Dhandhania, Soibam Pahel Meitei, Srinivas Kulkarni, Arindam Chatterjee
Publikováno v:
IP Journal of Nutrition, Metabolism and Health Science. 5:91-99
More than two billion people suffer from micronutrient deficiencies (MiNDs) globally, with nearly half living in India. The current risk of ‘hidden hunger’ is severe in India due to serious deficiency risks across an array of essential micronutri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7d9d23e1d9d0a1efee80c1f92c203c9
https://doi.org/10.18231/j.ijnmhs.2022.017
https://doi.org/10.18231/j.ijnmhs.2022.017
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:2383-2398
Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness in the working-age population across the globe. The objective of the present study was to assess the drug utilization pattern, risk factors and prevalence of diabetic ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b34bc736942914a7426987cbe5aab059
https://doi.org/10.26452/ijrps.v11i2.2229
https://doi.org/10.26452/ijrps.v11i2.2229
Autor:
Madhavi Mannam, Naveen Babu Kilaru, Dhanalakshmi Pinnika, Lavanya Nalluri, Anjani Kumar C, Jaidev Sudagani, Mounika Pothuraju, Ravindrababu Pingili
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:93-108
Diabetic nephropathy is the leading cause of the end-stage renal disease (ESRD) worldwide, and it is estimated that ~ 20% of type 2 diabetic patients reach ESRD during their lifetime. The objective of the present study was to assess the drug utilizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2390c13f60ef9ca8f68ce3d68300c60e
https://doi.org/10.26452/ijrps.v11i1.1791
https://doi.org/10.26452/ijrps.v11i1.1791
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 10, Iss 8, Pp BC19-BC23 (2016)
Introduction There were 72 million adults with Diabetes Mellitus (DM) in 2013 in the South East Asian region of which India is a part. This figure is expected to rise to more than 123 million by 2035. Some studies have also shown that there is an inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0970f38928b03613fe951a780c1614b4
https://doi.org/10.7860/jcdr/2016/21624.8381
https://doi.org/10.7860/jcdr/2016/21624.8381
Autor:
Jaidev, Sudagani, Tara, Kearney
Publikováno v:
The Practitioner. 251(1696)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0be38c246363aff3d0195f6c3a510d3
https://pubmed.ncbi.nlm.nih.gov/17784664
https://pubmed.ncbi.nlm.nih.gov/17784664